3D-QSAR, molecular docking, and molecular dynamic simulations for prediction of new Hsp90 inhibitors based on isoxazole scaffold. (scientific article published on 9 May 2017)

Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues

Q27644429

N-aryl-benzimidazolones as novel small molecule HSP90 inhibitors

Q27666051

Discovery of potent N-(isoxazol-5-yl)amides as HSP90 inhibitors

Q27695705

VMD: visual molecular dynamics

Q27860554

PRODRG: a tool for high-throughput crystallography of protein-ligand complexes

Q27860633

Targeting of the protein chaperone, HSP90, by the transformation suppressing agent, radicicol

Q28274103

QSAR-based models for designing quinazoline/imidazothiazoles/pyrazolopyrimidines based inhibitors against wild and mutant EGFR

Q28540324

Combined structure-based pharmacophore and 3D-QSAR studies on phenylalanine series compounds as TPH1 inhibitors

Q28727996

Discovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy

Q34111364

The Hsp90 chaperone machinery

Q34774579

Virtual Screening with AutoDock: Theory and Practice

Q34867648

4,5,6,7-Tetrahydro-isoxazolo-[4,5-c]-pyridines as a new class of cytotoxic Hsp90 inhibitors

Q35102273

Synthesis and biological evaluation of 3,5-disubstituted-4-alkynylisoxozales as a novel class of HSP90 inhibitors

Q38860002

Isoxazolo(aza)naphthoquinones: a new class of cytotoxic Hsp90 inhibitors

Q39357944

Novel 3,4-isoxazolediamides as potent inhibitors of chaperone heat shock protein 90.

Q39446477

A study on quantitative structure-activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold.

Q40385436

Prediction of dual agents as an activator of mutant p53 and inhibitor of Hsp90 by docking, molecular dynamic simulation and virtual screening

Q40639078

3D QSAR investigations on antimalarial naphthylisoquinoline alkaloids by comparative molecular similarity indices analysis (CoMSIA), based on different alignment approaches

Q41916451

Molecular modeling of Helicobacter pylori arginase and the inhibitor coordination interactions.

Q43192203

Molecular dynamics simulation by GROMACS using GUI plugin for PyMOL.

Q45334092

The co-chaperone p23 arrests the Hsp90 ATPase cycle to trap client proteins

Q46887356

Investigating the binding mechanism of novel 6-aminonicotinate-based antagonists with P2Y12 by 3D-QSAR, docking and molecular dynamics simulations.

Q47605957

Improved Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of pKa Values.

Q51550011

Pharmacophore model prediction, 3D-QSAR and molecular docking studies on vinyl sulfones targeting Nrf2-mediated gene transcription intended for anti-Parkinson drug design.

Q53792938

Studies of N(9)-arenthenyl purines as novel DFG-in and DFG-out dual Src/Abl inhibitors using 3D-QSAR, docking and molecular dynamics simulations.

Q55070175

Definition and testing of the GROMOS force-field versions 54A7 and 54B7

Q56225271

Synthesis of 5,6-dihydro-4H -benzo[d ]isoxazol-7-one and 5,6-dihydro-4H -isoxazolo[5,4-c ]pyridin-7-one Derivatives as Potential Hsp90 Inhibitors

Q59080586

P433

issue

P304

page(s)

1463-1478